These findings require replication in additional cohorts and further mechanistic research is needed to identify how changes in ANK1 methylation influence NAFLD or how NAFLD may influence ANK1 methylation and gene expression. This evidence concerns the gene ANK1 and metabolic dysfunction-associated steatotic liver disease.